期刊
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
卷 49, 期 4, 页码 825-840出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.rdc.2023.06.009
关键词
Regulatory T cells; Tregopathy; Autoimmune disease; Primary immune regulatory disorder; Inborn error of immunity; IPEX; Stem cell transplantation; Gene thereapy
类别
Regulatory T cells (Tregs) are essential for immune tolerance, and disorders of Tregs can lead to immune dysregulation. This review focuses on monogenic inborn errors of immunity (IEIs) affecting Treg development, stability, and function, leading to autoimmune, atopic, and infectious manifestations.
Regulatory T cells (Tregs) play a crucial role in enforcing immune tolerance in the periphery, preventing the activation of autoreactive cells, production of autoantibodies, and development of autoimmune and allergic diseases. Through both cell contactdependent and independent mechanisms, Tregs downmodulate responses of autoreactive T and B cells, shift antigen presenting cells (APCs) from being immune stimulatory to tolerogenic, and achieve their agenda of maintaining immune tolerance.1 It is thus not surprising that disorders of Tregs, or Tregopathies, lead to widespread immune dysfunction. In this review, we focus on monogenic inborn errors of immunity (IEIs) leading to impaired Treg development, stability, and function with subsequent immune dysregulation. These conditions may present throughout life with autoimmune, atopic, and infectious manifestations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据